FDA Map
FDAMAP is a group of global healthcare experts that conducts highly informative conferences, workshops and other training sessions for pharma, diagnostics and medical device industry professionals. Our panels of speakers include experts in clinical trials, data management, statistics, regulatory affairs, safety reporting, pharmacovigilance, social media marketing of medical products (drugs, biologics and medical devices), project management, GMP, GCP GLP, FDA/EMA audits, and information technology. Learn more about our Training and Consultancy Programs (Regulatory Workshops, FDA Seminars and Conferences, and Regulatory Consultancy) on our website www.fdamap.com
We work with professionals, regulators, and government agencies to build unique platforms for consultation, training, networking, and professional development. We strive hard to make high quality, mutually beneficial relationships with our customers and partners alike.
The FDAMap initiative is the newest venture of a group of leading experts from the industry and government to bring professionals at all levels together to create best practices based on logic, logistics, legal, and least-burdensome compliance. Visit: www.fdamap.com
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Company Details
Latest Content from PMHub
Redefining Pediatric Epilepsy Care: Why We Must Move Beyond Symptom Suppression
Press Releases | October 21, 2026 | Medscape Education
For families navigating pediatric epilepsy, the condition dictates every moment of their lives. The constant, crippling "anticipatory anxiety" of when the next seizure might hit transforms daily activities like grocery...
What the Most Favored Nation (MFN) policy means for UK Pharma
White Papers and Resources | October 20, 2026 | Amiculum
By Jed Avissar and Manca Povsic
ANTHEM strengthens team with three appointments following Healthy Influence launch
Press Releases | October 19, 2026 | Resonant Group
Healthcare communications consultancy welcomes new talent as it invests in its next phase of growth
Access The Vector Issue 3: 15 payers describe the likely affect of EU General Pharmaceutical Legislation on orphan drug strategy
Press Releases | October 14, 2026 | Genesis Research Group
In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they believe the new EU General Pharmaceutical Legislation will...
Your AI pilot works. That’s the problem.
White Papers and Resources | October 14, 2026 | 11 London
What breaks when you scale it won't be the model. It'll be your data.
“We’ve been told we can’t touch AI”
White Papers and Resources | October 14, 2026 | 11 London
It's not been a great few weeks for anyone trying to make the calm, sensible case for AI tools. Researchers have been quitting the big labs, including Anthropic, and going...
What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness
Press Releases | October 12, 2026 | Medscape Education
At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented...
On GLOBE Final Rule
Press Releases | October 9, 2026 | Genesis Research Group
The publication of the GLOBE Final Rule provides important clarity on the administration's approach to MFN pricing and what it could mean for pharmaceutical pricing, reimbursement, and access strategy globally....
Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation
Press Releases | October 8, 2026 | Medscape Education
Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.
Pharma leadership strategies for talent, AI adoption, and continuous learning
White Papers and Resources | October 8, 2026 | Inizio
In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to augment the workforce, encourage continuous...